DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma
BackgroundEpigenetic changes of lung adenocarcinoma (LUAD) have been reported to be a relevant factor in tumorigenesis and cancer progression. However, the molecular mechanisms responsible for DNA methylation patterns in the tumor immune-infiltrating microenvironment and in cancer immunotherapy rema...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.734873/full |
id |
doaj-1710701861764898976a0ae10ac8a15b |
---|---|
record_format |
Article |
spelling |
doaj-1710701861764898976a0ae10ac8a15b2021-09-06T05:54:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-09-011110.3389/fonc.2021.734873734873DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung AdenocarcinomaDidi YuanZehong WeiYicheng WangFang ChengYujie ZengLi YangShangyu ZhangJianbo LiRenkuan TangBackgroundEpigenetic changes of lung adenocarcinoma (LUAD) have been reported to be a relevant factor in tumorigenesis and cancer progression. However, the molecular mechanisms responsible for DNA methylation patterns in the tumor immune-infiltrating microenvironment and in cancer immunotherapy remain unclear.MethodsWe conducted a global analysis of the DNA methylation modification pattern (DMP) and immune cell-infiltrating characteristics of LUAD patients based on 21 DNA methylation regulators. A DNA methylation score (DMS) system was constructed to quantify the DMP model in each patient and estimate their potential benefit from immunotherapy.ResultsTwo DNA methylation modification patterns able to distinctly characterize the immune microenvironment characterization were identified among 513 LUAD samples. A lower DMS, characterized by increased CTLA-4/PD-1/L1 gene expression, greater methylation modifications, and tumor mutation burden, characterized a noninflamed phenotype with worse survival. A higher DMS, characterized by decreased methylation modification, a greater stromal-relevant response, and immune hyperactivation, characterized an inflamed phenotype with better prognosis. Moreover, a lower DMS indicated an increased mutation load and exhibited a poor immunotherapeutic response in the anti-CTLA-4/PD-1/PD-L1 cohort.ConclusionEvaluating the DNA methylation modification pattern of LUAD patients could enhance our understanding of the features of tumor microenvironment characterization and may promote more favorable immunotherapy strategies.https://www.frontiersin.org/articles/10.3389/fonc.2021.734873/fulllung adenocarcinoma (LUAD)DNA methylationtumor microenvironmentimmunotherapymutation burden |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Didi Yuan Zehong Wei Yicheng Wang Fang Cheng Yujie Zeng Li Yang Shangyu Zhang Jianbo Li Renkuan Tang |
spellingShingle |
Didi Yuan Zehong Wei Yicheng Wang Fang Cheng Yujie Zeng Li Yang Shangyu Zhang Jianbo Li Renkuan Tang DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma Frontiers in Oncology lung adenocarcinoma (LUAD) DNA methylation tumor microenvironment immunotherapy mutation burden |
author_facet |
Didi Yuan Zehong Wei Yicheng Wang Fang Cheng Yujie Zeng Li Yang Shangyu Zhang Jianbo Li Renkuan Tang |
author_sort |
Didi Yuan |
title |
DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma |
title_short |
DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma |
title_full |
DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma |
title_fullStr |
DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma |
title_full_unstemmed |
DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma |
title_sort |
dna methylation regulator-meditated modification patterns define the distinct tumor microenvironment in lung adenocarcinoma |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-09-01 |
description |
BackgroundEpigenetic changes of lung adenocarcinoma (LUAD) have been reported to be a relevant factor in tumorigenesis and cancer progression. However, the molecular mechanisms responsible for DNA methylation patterns in the tumor immune-infiltrating microenvironment and in cancer immunotherapy remain unclear.MethodsWe conducted a global analysis of the DNA methylation modification pattern (DMP) and immune cell-infiltrating characteristics of LUAD patients based on 21 DNA methylation regulators. A DNA methylation score (DMS) system was constructed to quantify the DMP model in each patient and estimate their potential benefit from immunotherapy.ResultsTwo DNA methylation modification patterns able to distinctly characterize the immune microenvironment characterization were identified among 513 LUAD samples. A lower DMS, characterized by increased CTLA-4/PD-1/L1 gene expression, greater methylation modifications, and tumor mutation burden, characterized a noninflamed phenotype with worse survival. A higher DMS, characterized by decreased methylation modification, a greater stromal-relevant response, and immune hyperactivation, characterized an inflamed phenotype with better prognosis. Moreover, a lower DMS indicated an increased mutation load and exhibited a poor immunotherapeutic response in the anti-CTLA-4/PD-1/PD-L1 cohort.ConclusionEvaluating the DNA methylation modification pattern of LUAD patients could enhance our understanding of the features of tumor microenvironment characterization and may promote more favorable immunotherapy strategies. |
topic |
lung adenocarcinoma (LUAD) DNA methylation tumor microenvironment immunotherapy mutation burden |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.734873/full |
work_keys_str_mv |
AT didiyuan dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma AT zehongwei dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma AT yichengwang dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma AT fangcheng dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma AT yujiezeng dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma AT liyang dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma AT shangyuzhang dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma AT jianboli dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma AT renkuantang dnamethylationregulatormeditatedmodificationpatternsdefinethedistincttumormicroenvironmentinlungadenocarcinoma |
_version_ |
1717779903186731008 |